VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 83 filers reported holding VAXCYTE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $609,000 | +103.0% | 11,946 | +98.4% | 0.00% | – |
| Q2 2023 | $300,000 | +88.7% | 6,020 | +41.9% | 0.00% | – |
| Q1 2023 | $159,000 | -67.8% | 4,241 | -58.8% | 0.00% | – |
| Q4 2022 | $494,000 | +2252.4% | 10,296 | +1101.4% | 0.00% | – |
| Q3 2022 | $21,000 | +110.0% | 857 | +72.1% | 0.00% | – |
| Q2 2022 | $10,000 | -85.3% | 498 | -82.3% | 0.00% | – |
| Q1 2022 | $68,000 | -67.1% | 2,819 | -67.5% | 0.00% | – |
| Q4 2021 | $207,000 | +66.9% | 8,677 | +77.6% | 0.00% | – |
| Q3 2021 | $124,000 | +87.9% | 4,887 | +67.2% | 0.00% | – |
| Q2 2021 | $66,000 | +32.0% | 2,922 | +16.7% | 0.00% | – |
| Q1 2021 | $50,000 | +257.1% | 2,504 | +377.0% | 0.00% | – |
| Q4 2020 | $14,000 | +27.3% | 525 | +138.6% | 0.00% | – |
| Q3 2020 | $11,000 | +83.3% | 220 | +10.0% | 0.00% | – |
| Q2 2020 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |